Skip to main content
Log in

In Vivo Absorption Properties of Orally Administered Recombinant Human Interleukin-11

  • Published:
Pharmaceutical Research Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCES

  1. M. Czupryn, F. Bennett, J. Dube, K. Grant, H. Scoble, H. Sookdeo, and J. M. McCoy. Alanine-scanning mutagenesis of human interleuken 11: identification of regions important for biological activity. Ann. N. Y. Acad. Sci. 762:152–164 (1995).

    Google Scholar 

  2. S. J. Goldman. Preclinical biology of interleukin 11: a multifunctional hematopoietic cytokine with potent thrombopoietic activity. Stem Cells (Dayt) 13:462–471 (1995).

    Google Scholar 

  3. R. L. Peterson, L. Wang, L. Albert, J. C. Keith, Jr., and A. J. Dorner. Molecular effects of recombinant human interleukin-11 in the HLA-B27 rat model of inflammatory bowel disease. Lab. Invest. 78:1503–1512 (1998).

    Google Scholar 

  4. W. L. Trepicchio, M. Bozza, G. Pedneault and A. J. Dorner. Recombinant human IL-11 attenuates the inflammatory response through down-regulation of proinflammatory cytokine release and nitric oxide production. J. Immunol. 157:3627–3634 (1996).

    Google Scholar 

  5. A. Takagi, H. Masuda, Y. Takakura, and M. Hashida. Disposition characteristics of recombinant human interleukin-11 after a bolus intravenous administration in mice. J. Pharmacol. Exp. Ther. 275:537–543 (1995).

    Google Scholar 

  6. T. Uchida, K. Aoyama, K. Mori, T. Usui, T. Watanabe, Y. Takariki, N. Asahara, M. Hirose, T. Kimura, M. Tateishi, and S. Higuchi. Pharmacokinetics of [125I]-recombinant human interleukin-11:1 Absorption, distribution and excretion after subcutaneous administration to male rats. Eur. J. Drug Metab. Pharmacokinet. 23: 403–410 (1998).

    Google Scholar 

  7. K. Aoyama, T. Uchida, F. Takanuki, T. Usui, T. Watanabe, S. Higuchi, T. Toyoki, and H. Mizoguchi. Pharmacokinetics of recombinant human inteleukin-11 (rhIL-11) in healthy male subjects. Br. J. Clin. Pharmacol. 43:571–578 (1997).

    Google Scholar 

  8. D. J. Hnatowich, W. W. Layne, and R. L. Childs. The preparation and labeling of DTPA-coupled albumin. Int. J. Appl. Radiat. Isot. 33:327–332 (1982).

    Google Scholar 

  9. H. Baumann, and J. Gauldie. The acute phase response [see comments]. Immunol. Today 15:74–80 (1994).

    Google Scholar 

  10. S. Neben, and K. Turner. The biology of interleukin 11. Stem Cells (Dayt) 11 Suppl 2: 156–162 (1993).

    Google Scholar 

  11. M. S. Gordon, W. J. McCaskill-Stevens, L. A. Battiato, J. Loewy, D. Loesch, E. Breeden, R. Hoffman, K. J. Beach, B. Kuca, J. Kaye, and G. W. Sledge, Jr. A phase I trial of recombinant human inteleukin-11 (neumega rhIL-11 growth factor) in women with breast cancer receiving chemotherapy. Blood 87:3615–3624 (1996).

    Google Scholar 

  12. C. Gabay, and I. Kushner. Acute-phase proteins and other systemic responses to inflammation. N. Engl. J. Med. 340:448–454 (1999).

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tseng, CM.L., Albert, L., Peterson, R.L. et al. In Vivo Absorption Properties of Orally Administered Recombinant Human Interleukin-11. Pharm Res 17, 482–485 (2000). https://doi.org/10.1023/A:1007545524408

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1007545524408

Navigation